Researchers showed that increasing prostatic stromal Foxf2 suppressed the growth and progression of both syngeneic and autochthonous mouse prostate cancer models in an immunocompetent context.
[Nature Communications]
Home Newsletters Stromal FOXF2 Suppresses Prostate Cancer Progression and Metastasis by Enhancing Antitumor Immunity
